Article
Future prospects for mitosis-targeted antitumor therapies
12 Jun 2021
Abstract excerpt
Dysregulation of cell cycle progression is a hallmark of cancer cells. In recent years, efforts have been devoted to the development of new therapies that target proteins involved in cell cycle regulation and mitosis. Novel targeted antimitotic drugs include inhibitors of aurora kinase family, polo-like kinase 1, Mps1, Eg5, CENP-5 and the APC/cyclosome complex. While certain new inhibitors reached the clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
